Home
Reels
Grupuri
Pagini
Anunturi
Arata mai mult
Grupuri Pagini Anunturi Events Blogs Funding Offers Jobs Courses Forums Movies Jocuri Merits
Conecteaza-te Inscrie-te
Theme Switcher
Night Mode
Innovations in Rare Disease Treatment: Ultomiris Market Overview
Ultomiris Drug Market: Transforming the Landscape of Rare Disease Treatment Ultomiris (ravulizAdd Newumab), developed by Alexion Pharmaceuticals and acquired by AstraZeneca in 2021, has emerged as a groundbreaking treatment for rare, complement-mediated disorders. As a long-acting monoclonal antibody, Ultomiris offers patients extended dosing intervals, enhancing convenience and adherence. This...
0 Commentarii ·0 Distribuiri ·309 Views ·0 previzualizare
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Sponsor
Upgrade to Pro
Alege planul care ți se potrivește
Upgrade
Sponsor